Empresa SenzaGen AB Nasdaq Stockholm
Acciones
Biotecnología e investigación médica
Precio de cierre
Otros sitios de cotización
|
||
- SEK | - |
Resumen de negocios
Ventas por actividad
SEK en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Genomic Allergen Rapid Detection
100,0
%
| 42 | 100,0 % | 50 | 100,0 % | +19,39 % |
Ventas por región
SEK en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Sweden
100,0
%
| 42 | 100,0 % | 50 | 100,0 % | +19,39 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Peter Nählstedt
CEO | Chief Executive Officer | 50 | 01/01/18 |
Marianne Olsson
DFI | Director of Finance/CFO | 63 | 01/11/16 |
Henrik Johansson
CTO | Chief Tech/Sci/R&D Officer | 42 | 01/01/14 |
Director/Board Member | 59 | 15/10/14 | |
Public Communications Contact | 56 | 01/01/18 | |
Helen Olsson
HRO | Human Resources Officer | 59 | 01/01/20 |
Corporate Officer/Principal | 51 | 01/01/17 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Founder | 76 | 18/08/10 | |
Director/Board Member | 59 | 15/10/14 | |
Paula Zeilon
BRD | Director/Board Member | 62 | 01/01/20 |
Director/Board Member | 65 | 01/01/20 | |
Peter Nählstedt
CEO | Chief Executive Officer | 50 | 01/01/18 |
Ian Kimber
BRD | Director/Board Member | 74 | 01/01/15 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 24 188 325 | 14 889 392 ( 61,56 %) | 0 | 61,56 % |
Información de la empresa
Sector
Varia. 1 de ene. | Capi. | |
---|---|---|
-31,90 % | 9586,32 M | |
-6,25 % | 3210,97 M | |
+25,95 % | 2918,66 M | |
-13,96 % | 2151,24 M | |
-16,83 % | 1788,88 M | |
+72,82 % | 1474,42 M | |
+29,17 % | 770 M | |
-2,62 % | 761 M | |
-26,33 % | 548 M |
- Bolsa de valores
- Acciones
- Acción SENZA
- Acción
- Empresa SenzaGen AB